Sponsorship Oligonucleotide SIG

Oligonucleotides Special Interest Group from Nucleic Acid Insights

Now in its second year, the Nucleic Acid Insights’ Oligonucleotides Special Interest Group (SIG) is an invitation-only initiative that brings senior experts together to build consensus, set priorities, and produce practical, open-access guidance for the field.

Interested in sponsoring the SIG?

Enquiry form

Oligonucleotide therapeutics are moving into larger patient populations and beyond the liver. Programs in obesity, cardiometabolic disease, and MASH will require metric-ton supply that current manufacturing was not designed for, while systemic delivery to extrahepatic tissues remains a major challenge. In 2027, this exclusive group will review progress against its 2026 outputs and extend its focus to extrahepatic delivery, under the Chatham House Rule in eight focus groups:

  • Synthesis platforms for large indications: scaling beyond solid-phase.
  • Downstream processing at commercial scale: from established platforms to a chromatography-free future.
  • Analytical tools innovation: keeping pace with new synthesis platforms and modalities.
  • Extrahepatic delivery beyond GalNAc: which tissues are within reach?
  • Oligonucleotide conjugates from design to CMC.
  • Securing the oligonucleotide supply chain: raw materials, capacity, and starting material control.
  • Translational and regulatory readiness: preclinical models, chronic dosing, and harmonization.
  • Commercial readiness: platform selection, freedom to operate, and CDMO capability.

Each focus group produces consensus statements that form the basis of the SIG’s outputs, which are then shared through Nucleic Acid Insights’ network of 16,500 life sciences professionals.

Why sponsor the SIG

Sponsoring puts your expert at the table where the field agrees what comes next for oligonucleotides, and your brand at the center of the solution.

Shape the agenda, not just follow it:

your expert sits as an integral part of the conversation alongside leading voices from across the field.

Create connections and generate leads:

at the core of every sponsorship is involvement in a focus group, giving you direct access to senior leaders.

Alignment with a credible initiative:

the SIG is an independent, editorially led initiative of hand-picked experts, with market-leading outputs throughout the year.

Association with consensus, not opinion:

each focus group produces consensus statements that form the basis of the SIG’s outputs, so your expert contributes to work that carries the weight of the group.

Visibility across the whole year:

sponsorship of the SIG gives year-round exposure with multiple touchpoints.

How the SIG works across the year

Each SIG cycle turns closed-door discussion into published priorities

Set the priorities

The Steering Committee leads discussion and prioritisation

Sponsor: your logo and link on the SIG website

Closed-door working groups

Small groups of experts meet under the Chatham House Rule

Sponsor: your expert takes a seat in the group of your choice

Build consensus

Members agree priorities, practical solutions and future direction

Sponsor: your expert helps shape the agreed position

Publish the SIG Report

An open-access report sets out the agreed recommendations

Sponsor: your logo, link and expert listed in the report

Take the outcomes to market

Webinars, infographics and emails keep the SIG in view all year

Sponsor: your chosen package delivers the follow-on content

Outcomes shape the next round

Sponsorship packages

Every package starts with your expert’s seat in a focus group, then sets how you take the outcomes to market. The team at BioInsights will work with you to find the best package for you based on your objectives.

SIG Discuss: Take the conversation live

Your expert carries the focus group’s conclusions to a live audience, alongside the key opinion leaders who shaped them. Your company is seen leading the conversation, not just taking part in it.

Best for: lead generation, people profiling, demonstrating expertise and networking

SIG Educate: Turn consensus into a resource

Complex conclusions become a clear, branded resource that people keep coming back to and pass on. Your brand becomes linked with making sense of the field’s hardest problems.

Best for: demonstrating expertise, brand awareness and networking

SIG Nurture: Follow up interest that already exists

Following the published report, your content is delivered directly to an audience that is already engaged, not one you have to win over from scratch.

Best for: lead generation, brand awareness and networking

SIG Research: Turn your seat into original insight

Alongside your expert’s place in a focus group, BioInsights runs an exclusive benchmarking research project, giving you original data on how the field compares.

Best for: launching new data, lead generation, brand awareness, demonstrating expertise and networking

Next steps

Focus group places are limited, and each is offered on an exclusive basis. To discuss sponsoring the 2027 Oligonucleotides SIG, including packages and investment, please complete the enquiry form.

Enquiry form

What members said about the 2026 SIG

“Very good forum for conversations on topics of high interest! Thank you for organizing and to the participants for sharing and contributing with your perspective and experience. That is what brings us together and understand what the future holds!”

– Sponsor

“I enjoyed the discussions greatly - it demonstrates the power of bringing folks together without regard to competition, etc. Excited about the innovation our field is driving forward.”

– Working group moderator

“Further great insights today (as also the case yesterday) - thought this was a very good workshop, well organized and focused - we should get some real benefit from consolidating the knowledge across the whole field.”

– SIG member

“The chosen format is excellent for this important discussion. We need more similar workshops like this one. Very insightful discussions are needed in this industry.”

– SIG member